XOMA Royalty (XOMA) Capital Expenditures Growth (1y) (2011 - 2017)
XOMA Royalty (XOMA) Capital Expenditures Growth (1y) (2011 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -157.14% |
| Dec 31, 2016 | 177.78% |
| Mar 31, 2016 | -86.22% |
| Dec 31, 2015 | -136.73% |
| Sep 30, 2015 | -59.18% |
| Jun 30, 2015 | 483.87% |
| Mar 31, 2015 | 359.18% |
| Dec 31, 2014 | -2.00% |
| Sep 30, 2014 | -30.00% |
| Jun 30, 2014 | -91.41% |
| Mar 31, 2014 | -90.16% |
| Dec 31, 2013 | -75.73% |
| Sep 30, 2013 | -78.48% |
| Jun 30, 2013 | -37.00% |
| Mar 31, 2013 | -9.12% |
| Dec 31, 2012 | -42.62% |
| Sep 30, 2012 | 193.09% |
| Jun 30, 2012 | -58.02% |
| Mar 31, 2012 | -38.29% |
| Dec 31, 2011 | 1,058.06% |